Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium tuberculosis | Phenolpthiocerol synthesis type-I polyketide synthase PpsD | 0.0153 | 0.4464 | 0.5935 |
Mycobacterium ulcerans | thioesterase TesA | 0.0132 | 0.3641 | 0.4813 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0042 | 0.012 | 0.2522 |
Wolbachia endosymbiont of Brugia malayi | 3-oxoacyl-ACP synthase | 0.004 | 0.0041 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0084 | 0.1745 | 0.1976 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks5 | 0.0154 | 0.4482 | 0.5959 |
Plasmodium falciparum | 3-oxoacyl-acyl-carrier protein synthase I/II | 0.004 | 0.0041 | 0.5 |
Mycobacterium ulcerans | multifunctional mycocerosic acid synthase membrane-associated Mas | 0.0163 | 0.4848 | 0.6426 |
Mycobacterium tuberculosis | Polyketide synthetase MbtC (polyketide synthase) | 0.0049 | 0.0407 | 0.0541 |
Mycobacterium ulcerans | Type I modular polyketide synthase | 0.0153 | 0.4464 | 0.5912 |
Mycobacterium leprae | PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSD | 0.0153 | 0.4464 | 0.5688 |
Toxoplasma gondii | type I fatty acid synthase, putative | 0.0113 | 0.289 | 0.5927 |
Mycobacterium leprae | Probable polyketide synthase Pks1 | 0.0163 | 0.4848 | 0.6229 |
Mycobacterium leprae | PROBABLE THIOESTERASE TESA | 0.0132 | 0.3641 | 0.4527 |
Brugia malayi | AMP-binding enzyme family protein | 0.0049 | 0.039 | 0.035 |
Schistosoma mansoni | methyltransferase-related | 0.0048 | 0.0352 | 1 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0042 | 0.012 | 0.0079 |
Mycobacterium tuberculosis | Phenolpthiocerol synthesis type-I polyketide synthase PpsC | 0.0153 | 0.4464 | 0.5935 |
Mycobacterium ulcerans | thioesterase | 0.0132 | 0.3641 | 0.4813 |
Mycobacterium tuberculosis | Probable fatty acid synthase Fas (fatty acid synthetase) | 0.005 | 0.0431 | 0.0574 |
Mycobacterium tuberculosis | Phenyloxazoline synthase MbtB (phenyloxazoline synthetase) | 0.0148 | 0.4266 | 0.5671 |
Mycobacterium ulcerans | polyketide synthase MbtD | 0.0049 | 0.039 | 0.0467 |
Loa Loa (eye worm) | AMP-binding enzyme family protein | 0.0148 | 0.4266 | 0.4897 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0042 | 0.012 | 0.2522 |
Mycobacterium ulcerans | phenolpthiocerol synthesis type-I polyketide synthase PpsB | 0.0122 | 0.3256 | 0.4298 |
Trypanosoma cruzi | beta-ketoacyl synthase family protein, putative | 0.004 | 0.0041 | 0.5 |
Mycobacterium ulcerans | fatty acid synthase Fas | 0.005 | 0.0431 | 0.0522 |
Mycobacterium tuberculosis | Probable multifunctional mycocerosic acid synthase membrane-associated Mas | 0.0163 | 0.4848 | 0.6445 |
Mycobacterium leprae | PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSB | 0.0122 | 0.3256 | 0.3984 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0042 | 0.012 | 0.0091 |
Toxoplasma gondii | type I fatty acid synthase, putative | 0.0163 | 0.4848 | 1 |
Mycobacterium ulcerans | Type I modular polyketide synthase | 0.0153 | 0.4464 | 0.5912 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks1 | 0.0114 | 0.2931 | 0.3896 |
Mycobacterium ulcerans | Type I modular polyketide synthase | 0.0153 | 0.4464 | 0.5912 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks8 | 0.0124 | 0.3337 | 0.4437 |
Mycobacterium ulcerans | phenolpthiocerol synthesis type-I polyketide synthase PpsD | 0.0153 | 0.4464 | 0.5912 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0042 | 0.012 | 1 |
Mycobacterium ulcerans | phenolpthiocerol synthesis type-I polyketide synthase PpsA | 0.0122 | 0.3256 | 0.4298 |
Mycobacterium ulcerans | phenolpthiocerol synthesis type-I polyketide synthase PpsC | 0.0163 | 0.4848 | 0.6426 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0042 | 0.012 | 1 |
Toxoplasma gondii | beta-ketoacyl synthase, N-terminal domain-containing protein | 0.0103 | 0.25 | 0.5115 |
Mycobacterium tuberculosis | Polyketide synthase Pks2 | 0.0154 | 0.4482 | 0.5959 |
Mycobacterium tuberculosis | Phenolpthiocerol synthesis type-I polyketide synthase PpsA | 0.0153 | 0.4464 | 0.5935 |
Mycobacterium tuberculosis | Hypothetical protein | 0.0048 | 0.0352 | 0.0468 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0048 | 0.0352 | 0.5 |
Onchocerca volvulus | Fatty acid synthase homolog | 0.0286 | 0.9634 | 1 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks7 | 0.0163 | 0.4848 | 0.6445 |
Plasmodium vivax | 3-oxoacyl-[acyl-carrier-protein] synthase i/ii, putative | 0.004 | 0.0041 | 0.5 |
Mycobacterium ulcerans | phenolpthiocerol synthesis type-I polyketide synthase PpsE | 0.01 | 0.237 | 0.3113 |
Mycobacterium tuberculosis | Polyketide synthase Pks12 | 0.0163 | 0.4848 | 0.6445 |
Loa Loa (eye worm) | fatty acid synthase | 0.0157 | 0.459 | 0.5273 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0042 | 0.012 | 1 |
Mycobacterium ulcerans | polyketide synthase Pks9 | 0.01 | 0.237 | 0.3113 |
Brugia malayi | Methyltransferase-like protein 4 | 0.0048 | 0.0352 | 0.0312 |
Loa Loa (eye worm) | acyl carrier protein | 0.0073 | 0.1332 | 0.1497 |
Chlamydia trachomatis | 3-oxoacyl-ACP synthase | 0.004 | 0.0041 | 0.5 |
Mycobacterium tuberculosis | Probable membrane bound polyketide synthase Pks6 | 0.0232 | 0.7522 | 1 |
Mycobacterium leprae | Probable multifunctional mycocerosic acid synthase membrane associated enzyme Mas | 0.0163 | 0.4848 | 0.6229 |
Mycobacterium tuberculosis | Polyketide synthetase MbtD (polyketide synthase) | 0.0049 | 0.039 | 0.0519 |
Mycobacterium tuberculosis | Conserved protein | 0.0048 | 0.0352 | 0.0468 |
Giardia lamblia | Methyltransferase like 2 | 0.0048 | 0.0352 | 0.5 |
Mycobacterium leprae | PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSE | 0.01 | 0.237 | 0.2734 |
Mycobacterium leprae | Polyketide synthase Pks13 | 0.0232 | 0.7522 | 1 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks15 | 0.0064 | 0.099 | 0.1316 |
Brugia malayi | Beta-ketoacyl synthase, N-terminal domain containing protein | 0.0153 | 0.4464 | 0.4441 |
Mycobacterium ulcerans | polyketide synthase | 0.0163 | 0.4848 | 0.6426 |
Trypanosoma brucei | beta-ketoacyl-ACP synthase | 0.004 | 0.0041 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0261 | 0.8668 | 1 |
Onchocerca volvulus | 0.0276 | 0.925 | 0.9285 | |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0042 | 0.012 | 1 |
Mycobacterium tuberculosis | Probable thioesterase TesA | 0.0132 | 0.3641 | 0.4841 |
Trypanosoma cruzi | beta-ketoacyl synthase family protein, putative | 0.004 | 0.0041 | 0.5 |
Toxoplasma gondii | AMP-binding enzyme domain-containing protein | 0.008 | 0.1614 | 0.3272 |
Mycobacterium ulcerans | polyketide synthase Pks13 | 0.0232 | 0.7522 | 1 |
Mycobacterium ulcerans | polyketide synthase | 0.0153 | 0.4464 | 0.5912 |
Mycobacterium tuberculosis | Polyketide synthase Pks13 | 0.0232 | 0.7522 | 1 |
Mycobacterium leprae | PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSA | 0.0153 | 0.4464 | 0.5688 |
Leishmania major | hypothetical protein, conserved | 0.0048 | 0.0352 | 1 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0042 | 0.012 | 0.2522 |
Mycobacterium leprae | PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSC | 0.0163 | 0.4848 | 0.6229 |
Brugia malayi | AMP-binding enzyme family protein | 0.0148 | 0.4266 | 0.4242 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks9 | 0.009 | 0.2004 | 0.2665 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
LD50 (ADMET) | > 1000 mg kg-1 | Acute toxicity in po dosed Mus musculus ICR (mouse) assessed as mortality measured after 14 days | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.